Davao City donates molnupiravir to region’s top hospital | Inquirer News
To boost treatment of mild virus cases

Davao City donates molnupiravir to region’s top hospital

/ 04:30 AM January 31, 2022

DAVAO CITY, Davao del Sur, Philippines — Amid the continued rise of COVID-19 cases in the Davao Region, the city government here has donated 40,000 capsules of the oral antiviral drug molnupiravir to Southern Philippines Medical Center (SPMC), the region’s biggest hospital, to boost treatment for mild and moderate coronavirus disease cases.

City Health Officer Ashley Lopez said the donation made up half of the 2,000 bottles ordered by the city that arrived here on Jan. 26.

The donation could treat for free around a thousand patients who exhibited mild to moderate symptoms of COVID-19, said Lopez, who handed the medicines to Dr. Ricardo Audan, SPMC chief.

Article continues after this advertisement

The remaining bottles would likely go to the city’s temporary treatment and monitoring facilities, he added.

FEATURED STORIES

SPMC has stopped its outpatient services since mid-January due to the increase in COVID-19 admissions. All of the hospital’s 87 intensive care unit beds and 478 ward beds for virus patients were fully occupied since Jan. 27.

Close monitoring

Lopez said other nonhospital treatment facilities would also get their share of the oral drug, which would be a big help especially for those who only experienced mild and moderate symptoms. Before its availability, those infected were given antiviral injectables, food and other supplements.

Article continues after this advertisement

“We can assure them (patients) that they will be well monitored if side effects happen, although we expect mild side effects based on its use in other countries,” Lopez said, referring to the antiviral drug, which was still under the emergency use authorization of the Food and Drug Administration.

—CARMELITO Q. FRANCISCO
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.